Tonix Pharmaceuticals Holding Corp (TNXP) Event June 21, 2022, 11:06 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Full text
Register to leave comments News bot Oct. 2, 2025, 8:25 a.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update Filing Date: 2022-06-21 Accepted: 2022-06-21 07:06:12 Event Type: Clinical Trial Update Event Details: Tonix Pharmaceuticals Holding Corp (TNXP) Announces Clinical Trial Update Tonix Pharmaceuticals Holding Corp (TNXP) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update. 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: Tonix Pharmaceuticals Holding CorpCIK: 0001430306Ticker Symbol: TNXPPeriod End Date: 2022-06-21Document Type: 8-K
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update
Filing Date: 2022-06-21
Accepted: 2022-06-21 07:06:12
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: